David-alexandre C Gros - Net Worth and Insider Trading
David-alexandre C Gros Net Worth
The estimated net worth of David-alexandre C Gros is at least $176,580 dollars as of 2024-05-17. David-alexandre C Gros is the SVP, Chief Business Officer of Alnylam Pharmaceuticals Inc and owns about 1,000 shares of Alnylam Pharmaceuticals Inc (ALNY) stock worth over $149,400. David-alexandre C Gros is also the CEO of Eledon Pharmaceuticals Inc and owns about 9,000 shares of Eledon Pharmaceuticals Inc (ELDN) stock worth over $27,180. Details can be seen in David-alexandre C Gros's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David-alexandre C Gros has not made any transactions after 2021-12-20 and currently still holds the listed stock(s).
Transaction Summary of David-alexandre C Gros
David-alexandre C Gros Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David-alexandre C Gros owns 3 companies in total, including Eledon Pharmaceuticals Inc (ELDN) , Neurocrine Biosciences Inc (NBIX) , and Alnylam Pharmaceuticals Inc (ALNY) .
Click here to see the complete history of David-alexandre C Gros’s form 4 insider trades.
Insider Ownership Summary of David-alexandre C Gros
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ELDN | Eledon Pharmaceuticals Inc | 2021-12-20 | director & Chief Executive Officer |
| NBIX | Neurocrine Biosciences Inc | 2017-01-09 | President & COO |
| ALNY | Alnylam Pharmaceuticals Inc | 2016-02-22 | SVP & Chief Business Officer |
David-alexandre C Gros Latest Holdings Summary
David-alexandre C Gros currently owns a total of 2 stocks. Among these stocks, David-alexandre C Gros owns 1,000 shares of Alnylam Pharmaceuticals Inc (ALNY) as of February 22, 2016, with a value of $149,400 and a weighting of 84.61%. David-alexandre C Gros also owns 9,000 shares of Eledon Pharmaceuticals Inc (ELDN) as of December 20, 2021, with a value of $27,180 and a weighting of 15.39%.
Latest Holdings of David-alexandre C Gros
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals Inc | 2016-02-22 | 1,000 | 149.40 | 149,400 |
| ELDN | Eledon Pharmaceuticals Inc | 2021-12-20 | 9,000 | 3.02 | 27,180 |
Holding Weightings of David-alexandre C Gros
David-alexandre C Gros Form 4 Trading Tracker
According to the SEC Form 4 filings, David-alexandre C Gros has made a total of 0 transactions in Alnylam Pharmaceuticals Inc (ALNY) over the past 5 years. The most-recent trade in Alnylam Pharmaceuticals Inc is the acquisition of 1,000 shares on February 22, 2016, which cost David-alexandre C Gros around $62,750.
According to the SEC Form 4 filings, David-alexandre C Gros has made a total of 2 transactions in Eledon Pharmaceuticals Inc (ELDN) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Eledon Pharmaceuticals Inc is the acquisition of 2,000 shares on December 20, 2021, which cost David-alexandre C Gros around $8,960.
Insider Trading History of David-alexandre C Gros
- 1
David-alexandre C Gros Trading Performance
GuruFocus tracks the stock performance after each of David-alexandre C Gros's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David-alexandre C Gros is -14.94%. GuruFocus also compares David-alexandre C Gros's trading performance to market benchmark return within the same time period. The performance of stocks bought by David-alexandre C Gros within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David-alexandre C Gros's insider trading performs compared to the benchmark.
Performance of David-alexandre C Gros
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.75 | | | | | |
| Relative Return to S&P 500(%) | -1.8 | | | | | |
David-alexandre C Gros Ownership Network
David-alexandre C Gros Owned Company Details
What does Eledon Pharmaceuticals Inc do?
Who are the key executives at Eledon Pharmaceuticals Inc?
David-alexandre C Gros is the director & Chief Executive Officer of Eledon Pharmaceuticals Inc. Other key executives at Eledon Pharmaceuticals Inc include other: See Explanation of Responses Biotechnology Value Fund L P , director & See Remarks Steven Perrin , and CHIEF FINANCIAL OFFICER Paul Sean Little .
Eledon Pharmaceuticals Inc (ELDN) Insider Trades Summary
Over the past 18 months, David-alexandre C Gros made no insider transaction in Eledon Pharmaceuticals Inc (ELDN). Other recent insider transactions involving Eledon Pharmaceuticals Inc (ELDN) include a net purchase of 1,978,932 shares made by Biotechnology Value Fund L P , and a net purchase of 1,000 shares made by Steven Perrin .
In summary, during the past 3 months, insiders sold 0 shares of Eledon Pharmaceuticals Inc (ELDN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eledon Pharmaceuticals Inc (ELDN) were sold and 1,979,932 shares were bought by its insiders, resulting in a net purchase of 1,979,932 shares.
Eledon Pharmaceuticals Inc (ELDN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eledon Pharmaceuticals Inc Insider Transactions
David-alexandre C Gros Mailing Address
Above is the net worth, insider trading, and ownership report for David-alexandre C Gros. You might contact David-alexandre C Gros via mailing address: 220 Marlborough Street, #6, Boston Ma 02116.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
